HopeStage
Back to all studies
Not recruitingEUCTR 2005-004383-23

Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid...

This historical record does not confirm current site availability.

Historical research recordIreland + United Kingdom
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with schizophrenia. Other eligibility criteria apply.

Listed locations
Ireland · United Kingdom
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
260
Sponsor
Janssen Cilag Ltd
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom, Ireland
Age range
Not clearly listed
Official registry ID
EUCTR 2005-004383-23
Official title
Show the full official title

Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid...

Recruitment & locations

Not recruiting

Ireland · United Kingdom

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen Cilag Ltd.

Who can participate?

This study is for people with schizophrenia. Other eligibility criteria apply.

Is this study still recruiting?

The historical registry lists this study as not recruiting.

Want to explore more studies?

Explore studies